ENA Respiratory raises $3M undisclosed

◆ Amount

$3M

◆ Announced

3 Sept 2026

◆ Company

◆ Source

◆ The Round

ENA Respiratory raised $3M in undisclosed funding, announced on 3 September 2026, led by Biointelect Venturer. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About ENA Respiratory

Clinical-stage biotech developing antiviral nasal spray treatments for respiratory viruses. ENA Respiratory is based in Australia and currently at undisclosed stage, operating in Health: Biotech.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links ENA Respiratory's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market